Target intelligence / Profile preview

Eyes shut homolog (EYS)

Target
EYS
Molecular classification
Other, extracellular matrix protein, EGF-like domain protein, laminin G-like domain protein, secreted glycoprotein
01

Overview

Eyes shut homolog (EYS) is a large secreted protein that contains multiple epidermal growth factor (EGF)-like domains and laminin G-like domains[1][2][3]. EYS is predominantly expressed in retinal photoreceptor cells and is essential for the organization and maintenance of photoreceptor cell structure, in particular the interphotoreceptor matrix and the connecting cilium, which is crucial for protein trafficking in the retina[3][4]. It is closely related to invertebrate proteins involved in compartmentalization of sensory epithelia. EYS interacts with the carbohydrate matriglycan through its LG domains, supporting photoreceptor survival[2]. Mutations in EYS are among the most frequent genetic causes of autosomal recessive retinitis pigmentosa, and can also cause cone-rod dystrophy[1][2][3][4]. The EYS gene is one of the largest human genes, with 44–46 exons and encoding a protein of approximately 3000 amino acids[1][3]. Loss of EYS function leads to disorganized retinal architecture and progressive visual impairment, but there are currently no approved drugs directly targeting EYS[1][3][4].

Other names
Eyes shutProtein eyes shut homologEYSC6orf178C6orf179C6orf180EGFL10EGFL11SPAMProtein spacemaker homologRP25bA166P24.2bA307F22.3bA74E24.1dJ1018A4.2dJ22I17.2dJ303F19.1Epidermal growth factor-like protein 10Epidermal growth factor-like protein 11
02

Biological functions

Photoreceptor morphogenesisPhotoreceptor maintenanceExtracellular matrix organization in retinaCiliary transport facilitation
03

Disease associations

Retinitis pigmentosa (autosomal recessive)Cone-rod dystrophy
04

Biomarkers

Retinal expression of EYS in genetic diagnosis and classification of autosomal recessive retinitis pigmentosa[1][3][4]

Beyond the preview

Go deeper on Eyes shut homolog (EYS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eyes shut homolog (EYS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call